Dr. Patrick Adrian Rendon, MD

Dr. Rendon practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Rendon's NPI, 1669615720, was assigned on April 19, 2009. Dr. Rendon graduated from University of New Mexico School of Medicine in 2009. Dr. Rendon holds New Mexico license MD2012-0256.

Dr. Rendon's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Rendon's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rendon practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Rendon's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Rendon is licensed in New Mexico.

CMS data shows 170 Medicare services from Dr. Rendon across 3 procedure codes in 2024, for 62 Medicare patients. Medicare paid $15,097 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 62 Medicare patients who saw Dr. Rendon in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rendon's median patient age at 70, with 44% women.

In 2024, Dr. Rendon wrote 55 Medicare Part D claims for 28 patients. 82% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Rendon for performance year 2024, reported as part of a group. Dr. Rendon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Rendon, published from 2016 to 2020. 2016 was the busiest year, with 2. Dr. Rendon has published most often in J Investig Med High Impact Case Rep. Dr. Rendon's most frequent co-authors are Jeffrey Brandon Aday, MD, Gurpreet Singh Dhaliwal, MD and Taylor B. Goot, MD.

CMS Open Payments shows 1 general payment to Dr. Rendon from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $112.

Dr. Rendon graduated from University of New Mexico School of Medicine in 2009.